Who owns TMCI?
Institutional ownership of Treace Medical Concepts Inc. from Form 13F, Q2 2026
117 institutional managers reported holding Treace Medical Concepts Inc. (TMCI) in Form 13F filings for Q2 2026, with 31,859,845 shares worth $127M. The largest reported holder was Armistice Capital, LLC. Managers that filed both quarters cut a net 4,099,707 shares (-11.4%). 31 opened new positions and 30 sold out.
- Funds holding
- 117
- Value held
- $127M
- New / sold out
- 31 / 30
- Net shares, same filers
- -11.4%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of TMCI
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Armistice Capital, LLC | $25.3M | 20.0% | 6,364,000 | Unchanged |
| Bank of America Corp | $13.2M | 10.4% | 3,305,100 | Added |
| Gagnon Securities LLC | $12.1M | 9.5% | 3,029,543 | Trimmed |
| Vanguard Capital Management LLC | $8.1M | 6.4% | 2,028,479 | Added |
| Gagnon Advisors, LLC | $6.1M | 4.8% | 1,534,034 | New |
| AQR Capital Management LLC | $6.0M | 4.7% | 1,497,673 | Added |
| BlackRock, Inc. | $5.5M | 4.3% | 1,380,021 | Trimmed |
| Marshall Wace, LLP | $5.3M | 4.2% | 1,328,592 | Added |
| CIBC Bancorp USA Inc. | $4.8M | 3.8% | 1,216,044 | Trimmed |
| Acadian Asset Management LLC | $3.7M | 2.9% | 928,177 | Trimmed |
| Millennium Management LLC | $2.9M | 2.3% | 738,628 | Trimmed |
| Weber Capital Management LLC | $2.3M | 1.9% | 589,617 | Unchanged |
| D. E. Shaw & Co., Inc. | $2.3M | 1.8% | 583,277 | Trimmed |
| Geode Capital Management, LLC | $2.3M | 1.8% | 573,796 | Trimmed |
| Citadel Advisors LLC | $2.1M | 1.6% | 516,994 | Trimmed |
| Goldman Sachs Group Inc | $2.0M | 1.5% | 492,116 | Added |
| Stifel Financial Corp | $1.7M | 1.4% | 435,009 | Added |
| UBS Group AG | $1.5M | 1.2% | 366,445 | Trimmed |
| Jacobs Levy Equity Management, Inc | $1.4M | 1.1% | 363,729 | Added |
| Raymond James Financial Inc | $1.3M | 1.0% | 331,110 | Trimmed |
| Morgan Stanley | $1.3M | 1.0% | 320,026 | Added |
| Vanguard Fiduciary Trust Co | $1.2M | 0.9% | 292,504 | Trimmed |
| Charles Schwab Investment Management Inc | $1.1M | 0.9% | 282,538 | Trimmed |
| State Street Corp | $932K | 0.7% | 234,271 | Trimmed |
| Susquehanna International Group, LLP | $853K | 0.7% | 214,219 | Added |
Share of 13F holdings is each fund's shares as a share of the 31,859,845 TMCI shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Gagnon Advisors, LLC New+$6.1M
- Marshall Wace, LLP Added+$4.2M
- Vanguard Capital Management LLC Added+$2.3M
- AQR Capital Management LLC Added+$1.7M
- Stifel Financial Corp Added+$1.0M
- Susquehanna International Group, LLP Added+$785K
- Jain Global LLC Added+$672K
- Goldman Sachs Group Inc Added+$416K
- Morgan Stanley Added+$399K
- Jacobs Levy Equity Management, Inc Added+$398K
Biggest sellers in Q2 2026
- Gagnon Securities LLC Trimmed-$8.6M
- BlackRock, Inc. Trimmed-$7.8M
- State Street Corp Trimmed-$4.0M
- Renaissance Technologies LLC Trimmed-$1.9M
- Geode Capital Management, LLC Trimmed-$1.7M
- Millennium Management LLC Trimmed-$1.6M
- Gsa Capital Partners LLP Trimmed-$1.4M
- Citadel Advisors LLC Trimmed-$1.2M
- Vanguard Portfolio Management LLC Trimmed-$1.1M
- D. E. Shaw & Co., Inc. Trimmed-$1.0M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $21.8M and sold $35.7M; 37 added and 32 trimmed.
Schedule 13D and 13G filings on TMCI
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-16ARMISTICE CAPITAL, LLC SCHEDULE 13G filed by Treace Medical Concepts Inc.Schedule 13G
- 2026-05-14BANK OF AMERICA CORP /DE/ SCHEDULE 13G filed by Treace Medical Concepts Inc.Schedule 13G
- 2025-05-15GAGNON SECURITIES LLC SCHEDULE 13G filed by Treace Medical Concepts Inc.Schedule 13G
Questions about TMCI ownership
- Who owns TMCI stock?
- 117 institutional investment managers reported TMCI positions in their Form 13F filings for Q2 2026, holding 31,859,845 shares worth $127M in total. Armistice Capital, LLC reported the largest position.
- Are funds buying or selling TMCI?
- In Q2 2026, 31 managers opened new TMCI positions, 37 added, 32 trimmed and 30 sold out. Managers that filed in both quarters sold a net 4,099,707 shares.
- How current is this TMCI institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to TMCI by CUSIP. Options are left out. TMCI news and filings · TMCI insider trades · Top funds